Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/56226
Title: Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects.
Other Titles: Riesgo cardiovascular residual de origen lipídico. Componentes y aspectos fisiopatológicos.
Authors: 
Keywords: 
Mesh: 
Issue Date: 24-Sep-2018
Citation: Clin Investig Arterioscler.2019;(31)2:75-88
Abstract: There is no doubt about the relationship between LDL-c and cardiovascular risk, as well as about the benefits of statin treatment. Once the objective of LDL-c has been achieved, the evidences that demonstrate the persistence of a high cardiovascular risk, a concept called residual risk, are notable. The residual risk of lipid origin is based on atherogenic dyslipidemia, characterized by an increase in triglycerides and triglyceride-rich lipoproteins, a decrease in HDL-c and qualitative alterations in LDL particles. The most commonly used measures to identify this dyslipidemia are based on the determination of total cholesterol, triglycerides, HDL, non-HDL cholesterol and remaining cholesterol, as well as apolipoprotein B100 and lipoprotein (a) in certain cases. The treatment of atherogenic dyslipidemia is based on weight loss and physical exercise. Regarding pharmacological treatment, we have no evidence of cardiovascular benefit with drugs aimed at lowering triglycerides and HDL-c, fenofibrate seems to be effective in situations of atherogenic dyslipidemia.
PMID: 30262442
URI: https://hdl.handle.net/20.500.12530/56226
Appears in Collections:Centros de Atención Primaria > Artículos

Files in This Item:
The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.


This item is licensed under a Creative Commons License Creative Commons